Search

The eighth edition of Glycobasque turned San Sebastián into a hub for glycoscience research on October 23–24. The meeting, led by Asparia Glycomics in collaboration with the research centers CIC

The biotech company Inhibitec is advancing the development of an antibody targeting the BAMBI molecule, with therapeutic potential for both psoriasis and psoriatic arthritis.

The public research ecosystem of the Barcelona Science Park (PCB-UB) continues to expand, achieving 84.6 million euros in funding in 2024, 20.8% more than the previous year and the highest figure ever

At AseBio, our Sustainability Commission has prepared the report “Biotechnology Applied to the Green Transition,” which analyzes the solutions, areas of action, distribution, and challenges of our

It will take the form of an omnibus law, bringing together multiple provisions on health, clinical trials, in vitro diagnostics, medical devices, food, and feed. The second phase, focused on

BIOSPAIN, the largest biotechnology event organised by a national bioindustry association in Europe, closed its 12th edition in Barcelona on October 9 after three days of events with AseBio as

According to the AECC, around 35,875 new cases were diagnosed in 2024, accounting for nearly 29% of all tumors detected in women.

On World Food Day 2025, biotechnology emerges as a driving force for building more sustainable, inclusive, and future-ready food systems.

The International Biotechnology Meeting BIOSPAIN 2025 was held from October 7 to 9 at the Fira de Barcelona – Montjuïc.

Meet Fundación para la Investigación de Sanitas Hospitales, our new member. We spoke with José Francisco Tomás, president of FISH.

Meet Succipro, our new member. We spoke with Isabel Huber Ruano, CEO

The edition closes with more than 2,400 attendees from over 1,000 organizations across 34 countries. BIOSPAIN 2025 brought together 140 investors representing 76 national and international investment

Artificial intelligence enables the analysis of millions of biological data points to identify optimal solutions, while automation facilitates the transfer of results from the lab to industry.

The Spanish biotech ecosystem, despite its progress in investment, R&D, business creation, and international visibility, still needs to strengthen public-private collaborations and take greater

The upcoming Biotech Act and the European Pharmaceutical Strategy are crucial for the development of advanced therapies in Europe, as they aim to create a more agile and predictable regulatory

We spoke with Gonzalo de Miquel, Vice President of Global Clinical Development at Alexion Pharmaceuticals (AstraZeneca Rare Disease), Gold Sponsor of BIOSPAIN 2025.

From October 7–9, the Fira de Barcelona will host the 12th edition of BIOSPAIN, organized by AseBio and Biocat, in collaboration with the Government of Catalonia and the Barcelona City Council.

AseBio presents at BIOSPAIN 2025 the report “The new geopolitics of biotechnology”, which analyzes the global race of the sector and Spain’s strategic role in the new balance of power among the United

Carlos Mackintosh, Senior Principal Scientist, Translational IPS, Bristol Myers Squibb – CITRE and Silver Sponsor of BIOSPAIN, highlights the strategic role of the Center for Innovation and

Jose Terencio, Senior Vice President, Discovery at Grifols and Gold Sponsor of BIOSPAIN, reaffirms the company’s commitment to open innovation as a driving force to diversify its pipeline, accelerate

Pilar Gil, coCEO of SID and Platinum Sponsor of BIOSPAIN 2025, highlights the importance of having flexible infrastructures and collaborative ecosystems as key elements for the development and growth